‘Redesigned’ antibodies may control HIV: study

With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody.

U.S. Ambassador addresses progress fighting AIDS

Targeting HIV’s “cap”

New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target.

BHT grant to help Comprehensive Care Clinic’s medication program

The Vanderbilt Comprehensive Care Clinic has received a nearly $54,000 grant for 2014-2015 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS.

Traditional healers contribute to HIV care delays: study

If you’re a native of rural Mozambique who contracts HIV and becomes symptomatic, before seeking clinical testing and treatment, you’ll likely consult a traditional healer.

Study tracks new way to fight HIV infection in women

Vanderbilt University’s Richard Caprioli, Ph.D., is participating in a national, federally funded collaboration to develop an intravaginal ring capable of delivering antiretroviral drugs to women at risk for HIV infection.